| Femara Dosages & Strengths | ||||
|---|---|---|---|---|
| Strength | Format | Route | Strength | Class |
| Femara 2.5 mg | tablet | oral | 1.0 each | OTC |
Posted by chicago68 2 months ago
I HAVE BEEN ON FEMARA FOR 1 YEAR, MY HOT FLASHES HAVE INCREASED A LOT AND MY HAIR SEEMS TO BE FALLING OUT IN HAND FULLS WHAT...
Posted by alabamawoman09 6 months ago
I have been on Femara for nearly 7 months now and my BP is slowly rising to horrible number,i was recently put on Coreg two t...
Posted by bcc27521 8 months ago
I am a 46 yr. old woman diagnosed with breast cancer last April 2008. I had left mast. a month after and then had chemo on Ju...
Compulsory licensing of cancer meds can save Bt4 bn in 5 years - Thai News Agency MCOT
... Erlotinib, sold as Tarceva by Roche and used to treat non-small cell lung cancer; and Letrozole used to treat breast cancer, sold as Femara by Novartis. ...
Fri Mar 07 08:26:08 -0500 2008
No cancellation of CL for cancer drugs : Chaiya - Nation Multimedia
... imposed on January 4 are docetaxel, sold as Taxotere by Sanofi Aventis; erlotinib, sold as Tarceva by Roche; and letrozole, sold as Femara by Novartis. ...
Mon Mar 03 06:55:26 -0500 2008
Zometa® Shows Promise in Preventing Bone Lose Among Women Using ... - Cancer Consultants
A recent study found that Zometa® (zoledronic acid) may prevent bone loss in women treated with Femara® (letrozole) for breast cancer. ...
Wed Feb 27 15:56:08 -0500 2008
letrozole - A nonsteroidal inhibitor of estrogen synthesis that resembles paclitaxel in chemical structure. As a third-generation aromatase inhibitor, letrozole selectively and reversibly inhibits aromatase, a cytochrome P-450 enzyme complex found in many tissues including those of the premenopausal ovary, liver, and breast; aromatase catalyzes the aromatization of androstenedione and testosterone into estrone and estradiol, the final step in estrogen biosynthesis. In estrogen-dependent breast cancers, anastrozole may inhibit tumor growth. (NCI04)